Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis

NCT02932449 is registered in ClinicalTrials.gov with Target PharmaSolutions, Inc. as lead sponsor.

NCT NCT02932449
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02932449 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis
Lead sponsor
Target PharmaSolutions, Inc.
Phase
Observational
Overall status
Completed
Start date
October 31, 2016
Completion date
January 23, 2025
Enrollment
711 (actual)
Sites
39

Conditions

As the registry lists them; a condition with its own page is linked.

biliary cirrhosis, primary